ESTA — Establishment Labs Holdings Share Price
0.000.00%
Last trade - 00:00- $866.38m
- $995.61m
- $166.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.32 | ||
| Price to Tang. Book | 21.55 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.22 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.95% | ||
| Return on Equity | -236.67% | ||
| Operating Margin | -30.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 84.68 | 126.68 | 161.7 | 165.15 | 166.03 | 206.92 | 258.29 | 13.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Directors
- Nicholas Lewin CHM (43)
- Juan Jose Chacon Quiros CEO (49)
- Raj Denhoy CFO (51)
- Salvador Santos COO (38)
- Roberto De Mezerville CTO (40)
- Eddie De Oliveira VPR (38)
- Alberto Quesada VPR (54)
- Neeta Toprani GCN
- Leslie Gillin DRC
- Lisa Colleran IND (63)
- Dennis Condon IND (84)
- Ann Custin IND
- Lisa Gersh IND (62)
- Edward Schutter IND (69)
- Bryan Slotkin IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 9th, 2013
- Public Since
- July 19th, 2018
- No. of Shareholders
- 21
- No. of Employees
- 1,018
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 28,908,360
- Address
- Building B15 And 25 Coyol Free Zone, ALAJUELA, 20101
- Web
- https://establishmentlabs.com
- Phone
- +506 24342400
- Contact
- Rajbir Denhoy
- Auditors
- Marcum LLP
Upcoming Events for ESTA
Q1 2025 Establishment Labs Holdings Inc Earnings Call
Establishment Labs Holdings Inc Annual Shareholders Meeting
Establishment Labs Holdings Inc Annual Shareholders Meeting
Establishment Labs Holdings Inc To Host Investor Day
Q2 2025 Establishment Labs Holdings Inc Earnings Release
Similar to ESTA
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Establishment Labs Holdings share price?
As of Today at 20:31 UTC, shares in Establishment Labs Holdings are trading at $29.97. This share price information is delayed by 15 minutes.
How has the Establishment Labs Holdings share price performed this year?
Shares in Establishment Labs Holdings last closed at $29.97 and the price had moved by -38.26% over the past 365 days. In terms of relative price strength the Establishment Labs Holdings share price has underperformed the S&P500 Index by -43.01% over the past year.
What are the analyst and broker recommendations for Establishment Labs Holdings?
The overall consensus recommendation for Establishment Labs Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Establishment Labs Holdings dividend yield?
Establishment Labs Holdings does not currently pay a dividend.
Does Establishment Labs Holdings pay a dividend?
Establishment Labs Holdings does not currently pay a dividend.
When does Establishment Labs Holdings next pay dividends?
Establishment Labs Holdings does not currently pay a dividend.
How do I buy Establishment Labs Holdings shares?
To buy shares in Establishment Labs Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Establishment Labs Holdings?
As of the previous close price of $29.97, shares in Establishment Labs Holdings had a market capitalisation of $866.38m.
Where are Establishment Labs Holdings shares listed?
Here are the trading details for Establishment Labs Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ESTA
What kind of share is Establishment Labs Holdings?
Based on an overall assessment of its quality, value and momentum Establishment Labs Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Establishment Labs Holdings share price forecast for 2025?
The analyst consensus target price for shares in Establishment Labs Holdings is $55.00. That is 83.52% above the last closing price of $29.97.
Analysts covering Establishment Labs Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$2.06 for the next financial year.
Find out moreWhat is the trend in the Establishment Labs Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Establishment Labs Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -29.24%.
As of the last closing price of $29.97, shares in Establishment Labs Holdings were trading -26.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Establishment Labs Holdings PE Ratio?
The Establishment Labs Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $29.97.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Establishment Labs Holdings?
Establishment Labs Holdings' management team is headed by:
- Nicholas Lewin - CHM
- Juan Jose Chacon Quiros - CEO
- Raj Denhoy - CFO
- Salvador Santos - COO
- Roberto De Mezerville - CTO
- Eddie De Oliveira - VPR
- Alberto Quesada - VPR
- Neeta Toprani - GCN
- Leslie Gillin - DRC
- Lisa Colleran - IND
- Dennis Condon - IND
- Ann Custin - IND
- Lisa Gersh - IND
- Edward Schutter - IND
- Bryan Slotkin - IND